264 related articles for article (PubMed ID: 22214475)
1. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease.
Marrs JC
Am J Manag Care; 2011 Dec; 17 Suppl 15():S403-11. PubMed ID: 22214475
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
3. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
Marrs JC; Saseen JJ
Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
[TBL] [Abstract][Full Text] [Related]
4. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
6. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
7. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease.
Norris K; Vaughn C
Expert Rev Cardiovasc Ther; 2003 May; 1(1):51-63. PubMed ID: 15030297
[TBL] [Abstract][Full Text] [Related]
8. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
[TBL] [Abstract][Full Text] [Related]
9. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
Ong HT
J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
[TBL] [Abstract][Full Text] [Related]
10. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
McCullough PA; Verrill TA
Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453
[TBL] [Abstract][Full Text] [Related]
11. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemias in patients who have chronic kidney disease.
Farbakhsh K; Kasiske BL
Med Clin North Am; 2005 May; 89(3):689-99. PubMed ID: 15755473
[TBL] [Abstract][Full Text] [Related]
13. [Chronic kidney disease and atherosclerosis].
Koike M; Nitta K
Nihon Rinsho; 2011 Jan; 69(1):144-50. PubMed ID: 21226275
[TBL] [Abstract][Full Text] [Related]
14. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
15. [Which optimal antihypertensive bitherapy for kidney patients?].
Bonne JF; Shahapuni I; Mailliez S; Oprisiu R; Temmar M; Choukroun G; Massy ZA; Fournier A
Nephrol Ther; 2007 Jun; 3(3):79-88. PubMed ID: 17540309
[TBL] [Abstract][Full Text] [Related]
16. [Management of hypertension in CKD patients].
Kusaba T; Kimura K
Nihon Rinsho; 2008 Sep; 66(9):1747-52. PubMed ID: 18788405
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
Castelino RL; Chen TF; Guddattu V; Bajorek BV
Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and chronic kidney disease: treatment options.
Wu-Wong JR
Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
[TBL] [Abstract][Full Text] [Related]
20. [The effects and new insights of ARB on CKD management].
Nakamichi T; Itoh S
Nihon Rinsho; 2009 Apr; 67(4):783-7. PubMed ID: 19348243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
